Anteilseigner
Neurocrine Biosciences (15,77 %) Armistice Capital LLC (8,59 %) EcoR1 Capital, LLC (7,20 %) The Vanguard Group, Inc. (5,79 %) BlackRock Fund Advisors (5,49 %) Farallon Capital Management LLC (4,21 %) SSgA Funds Management, Inc. (3,22 %) BlackRock Advisors LLC (1,91 %) Dimensional Fund Advisors LP (1,87 %) T. Rowe Price Associates, Inc. (Investment Management) (1,86 %) Geode Capital Management LLC (1,79 %) AQR Capital Management LLC (1,46 %) American Century Investment Management, Inc. (1,42 %) Vestal Point Capital LP (1,10 %) Federated MDTA LLC (1,01 %) Acadian Asset Management LLC (0,85 %) Northern Trust Investments, Inc.(Investment Management) (0,71 %) Bank of America, NA (Private Banking) (0,65 %) GlobeFlex Capital LP (0,57 %) Woodline Partners LP (0,55 %)
Kontakt
Voyager Therapeutics Inc.